Home / Brands / AEQUITA PHARMACY
AEQUITA PHARMACY Recalls
13 recalls on record · August 13, 2025 to August 13, 2025 · Drugs
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 2.67 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steril
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin injection solution, 2.21 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) su
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide +Cyanocobalamin 1.5 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steril
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.44 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steri
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 16.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 13.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile,
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 8.8 mg + 1.0mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 6.6 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Tirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2m
Hazard: Lack of Processing Controls.
August 13, 2025DrugsFDA
AEQUITA PHARMACY recalls Semaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Steril
Hazard: Lack of Processing Controls.